Your browser doesn't support javascript.
SARS-CoV-2 viral dynamics in non-human primates.
Gonçalves, Antonio; Maisonnasse, Pauline; Donati, Flora; Albert, Mélanie; Behillil, Sylvie; Contreras, Vanessa; Naninck, Thibaut; Marlin, Romain; Solas, Caroline; Pizzorno, Andres; Lemaitre, Julien; Kahlaoui, Nidhal; Terrier, Olivier; Ho Tsong Fang, Raphael; Enouf, Vincent; Dereuddre-Bosquet, Nathalie; Brisebarre, Angela; Touret, Franck; Chapon, Catherine; Hoen, Bruno; Lina, Bruno; Rosa Calatrava, Manuel; de Lamballerie, Xavier; Mentré, France; Le Grand, Roger; van der Werf, Sylvie; Guedj, Jérémie.
  • Gonçalves A; Université de Paris, IAME, INSERM, Paris, France.
  • Maisonnasse P; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Donati F; Unité de Génétique Moléculaire des Virus à ARN, GMVR: Institut Pasteur, UMR CNRS 3569, Université de Paris, Paris, France.
  • Albert M; Centre National de Référence des Virus des infections respiratoires (dont la grippe), Institut Pasteur, Paris, France.
  • Behillil S; Unité de Génétique Moléculaire des Virus à ARN, GMVR: Institut Pasteur, UMR CNRS 3569, Université de Paris, Paris, France.
  • Contreras V; Centre National de Référence des Virus des infections respiratoires (dont la grippe), Institut Pasteur, Paris, France.
  • Naninck T; Unité de Génétique Moléculaire des Virus à ARN, GMVR: Institut Pasteur, UMR CNRS 3569, Université de Paris, Paris, France.
  • Marlin R; Centre National de Référence des Virus des infections respiratoires (dont la grippe), Institut Pasteur, Paris, France.
  • Solas C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Pizzorno A; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Lemaitre J; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Kahlaoui N; Aix-Marseille Univ, APHM, Unité des Virus Emergents (UVE) IRD 190, INSERM 1207, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France.
  • Terrier O; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
  • Ho Tsong Fang R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Enouf V; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Dereuddre-Bosquet N; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
  • Brisebarre A; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Touret F; Unité de Génétique Moléculaire des Virus à ARN, GMVR: Institut Pasteur, UMR CNRS 3569, Université de Paris, Paris, France.
  • Chapon C; Centre National de Référence des Virus des infections respiratoires (dont la grippe), Institut Pasteur, Paris, France.
  • Hoen B; Plate-forme de microbiologie mutualisée (P2M), Pasteur International Bioresources Network (PIBnet), Institut Pasteur, Paris, France.
  • Lina B; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Rosa Calatrava M; Unité de Génétique Moléculaire des Virus à ARN, GMVR: Institut Pasteur, UMR CNRS 3569, Université de Paris, Paris, France.
  • de Lamballerie X; Centre National de Référence des Virus des infections respiratoires (dont la grippe), Institut Pasteur, Paris, France.
  • Mentré F; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, Marseille, France.
  • Le Grand R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • van der Werf S; Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
  • Guedj J; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
PLoS Comput Biol ; 17(3): e1008785, 2021 03.
Article in English | MEDLINE | ID: covidwho-1181165
ABSTRACT
Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large burst size (>104 virus) and a within-host reproductive basic number of approximately 6 and 4 in nasopharyngeal and tracheal compartment, respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours, with no significant association between cytokine elevation and clearance, leading to a median time to viral clearance of 10 days, consistent with observations in mild human infections. Given these parameter estimates, we predict that a prophylactic treatment blocking 90% of viral production or viral infection could prevent viral growth. In conclusion, our results provide estimates of SARS-CoV-2 viral kinetic parameters in an experimental model of mild infection and they provide means to assess the efficacy of future antiviral treatments.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Macaca fascicularis Type of study: Observational study / Prognostic study Limits: Animals Language: English Journal: PLoS Comput Biol Journal subject: Biology / Medical Informatics Year: 2021 Document Type: Article Affiliation country: JOURNAL.PCBI.1008785

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Macaca fascicularis Type of study: Observational study / Prognostic study Limits: Animals Language: English Journal: PLoS Comput Biol Journal subject: Biology / Medical Informatics Year: 2021 Document Type: Article Affiliation country: JOURNAL.PCBI.1008785